DRL
Location
Vlaams Brabant
Founded
1980-09-05
Website
Risk Signals
105 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Furniture, Catalog and Mail-Order Houses), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about DRL
Live alerts from global media, monitored by Business Radar
2024-10-01 (globenewswire.com)
Infinite Reality To Secure Majority Stake in Super League with Proposed Capital Commitment and Asset Transfer
Transaction will fuel the formation of a leading, global audience network operating at the intersection of pop culture, entertainment, and immersive...
Read more
2024-09-15 (businessday.ng)
Petrol from Dangote refinery will only be sold to NNPC, FG insists
As against NNPCL's claim of not being the sole off-taker of refined petrol from Dangote Refinery, Wale Edun says will only be sold to NNPC.
Read more
2024-05-08 (livemint.com)
New businesses and partnerships hold the key to Dr Reddy's growth | Stock Market News
With a crucial product in the US set to go off-patent in January 2026, the company has adopted a multi-pronged strategy comprising partnerships, acquisitions and new products to boost revenue.
Read more
2024-03-27 (livemint.com)
Dr. Reddy’s to promote and distribute Sanofi’s vaccine brands
The tie-up gives DRL a stronger portfolio and takes it to second place among vaccine players in India.
Read more
2016-10-26 (expresspharma.in)
DRL in pact with Gland Pharma in the US market -
To market and distribute a diverse portfolio of eight injectable ANDAs
Read more
(economictimes.com)
DRL share price: Dr Reddy's signs in-licensing pact with Ingenus Pharmaceuticals for cancer treatment injection -
Dr Reddy's Laboratories Ltd has signed a licensing agreement with US-based Ingenus Pharmaceuticals to commercialize Cyclophosphamide injection for cancer treatment. Dr Reddy's USA will commercialize the injection in the US market, paying Ingenus 50% of the calculated profit share.
Read more
(prnewswire.com)
Drone Racing League Lands Partnership with Google Cloud and Launches 2022-23 DRL Algorand World Championship Season with Drone Racing in Silicon Valley, Miami, and the Metaverse
/PRNewswire/ -- The Drone Racing League (DRL), the world's premier professional drone racing property, announced a partnership today with Google Cloud to...
Read more